Assignee
NPS PHARMA INC
US·74 granted patents·29 pending applications·2,089 citations·filing 1993–2016
Top patents by PatentIndex Score
103 records- 0198US9545434B2Treatment of short bowel syndrome patients with colon-in-continuityNPS PHARMA INC·Filed 2015·Granted Jan 17, 2017·38 cites·23 claims
- 0298US7847061B2Treatment of short bowel syndrome patients with colon-in-continuityNPS PHARMA INC·Filed 2005·Granted Dec 7, 2010·58 cites·18 claims
- 0398US6660753B2Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsNPS PHARMA INC·Filed 2002·Granted Dec 9, 2003·160 cites·58 claims
- 0497US5589351AFluorescence detection apparatusNPS PHARMA INC·Filed 1994·Granted Dec 31, 1996·180 cites·21 claims
- 0596US6211244B1Calcium receptor-active compoundsNPS PHARMA INC·Filed 1995·Granted Apr 3, 2001·251 cites·46 claims
- 0694US6429207B1Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseasesNPS PHARMA INC·Filed 2000·Granted Aug 6, 2002·67 cites·23 claims
- 0793US6031003ACalcium receptor-active moleculesNPS PHARMA INC·Filed 1995·Granted Feb 29, 2000·151 cites·145 claims
- 0891US6313146B1Calcium receptor-active moleculesNPS PHARMA INC·Filed 1995·Granted Nov 6, 2001·104 cites·55 claims
- 0990US7642241B2Methods of enhancing functioning of the large intestineNPS PHARMA INC·Filed 2007·Granted Jan 5, 2010·8 cites·9 claims
- 1090US6383527B1Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a NSAIDNPS PHARMA INC·Filed 1999·Granted May 7, 2002·117 cites·39 claims
- 1189US6001884ACalcium receptor-active moleculesNPS PHARMA INC·Filed 1995·Granted Dec 14, 1999·100 cites·44 claims
- 1289US5981599AInorganic ion receptor active compoundsNPS PHARMA INC·Filed 1997·Granted Nov 9, 1999·70 cites·27 claims
- 1387US6071970ACompounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseasesNPS PHARMA INC·Filed 1995·Granted Jun 6, 2000·66 cites·185 claims
- 1486US5648541AChiral reductions of imines leading to the syntheses of optically active aminesNPS PHARMA INC·Filed 1995·Granted Jul 15, 1997·34 cites·20 claims
- 1585US6750255B2Calcium receptor-active compoundsNPS PHARMA INC·Filed 2002·Granted Jun 15, 2004·19 cites·31 claims
- 1685US5504253AAmine preparationNPS PHARMA INC·Filed 1994·Granted Apr 2, 1996·18 cites·20 claims
- 1784US7235258B1Sustained-release formulations for treating CNS-mediated disordersNPS PHARMA INC·Filed 2000·Granted Jun 26, 2007·17 cites·8 claims
- 1884US7109238B2Calcilytic compoundsNPS PHARMA INC·Filed 2004·Granted Sep 19, 2006·13 cites·6 claims
- 1983US7074809B2CompoundsNPS PHARMA INC·Filed 2003·Granted Jul 11, 2006·23 cites·12 claims
- 2083US6362231B1Calcium receptor active compoundsNPS PHARMA INC·Filed 1997·Granted Mar 26, 2002·45 cites·30 claims
- 2182US7888317B2Glucagon-like peptide-2 and its therapeutic useNPS PHARMA INC·Filed 2006·Granted Feb 15, 2011·3 cites·4 claims
- 2282US7202261B2Calcilytic compoundsNPS PHARMA INC·Filed 2004·Granted Apr 10, 2007·13 cites·31 claims
- 2382US6818660B2Calcilytic compoundsNPS PHARMA INC·Filed 2001·Granted Nov 16, 2004·14 cites·15 claims
- 2482US6022894AMethod of using calcilytic compoundsNPS PHARMA INC·Filed 1997·Granted Feb 8, 2000·51 cites·30 claims
- 2581US7749543B2Methods useful in the treatment of bone resorption diseasesNPS PHARMA INC·Filed 2009·Granted Jul 6, 2010·3 cites·9 claims
- 2680US7053104B2Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseasesNPS PHARMA INC·Filed 2002·Granted May 30, 2006·9 cites·23 claims
- 2779US6939895B2Calcium receptor-active compoundsNPS PHARMA INC·Filed 2002·Granted Sep 6, 2005·10 cites·20 claims
- 2878US5962314ACalcium receptor-active moleculesNPS PHARMA INC·Filed 1997·Granted Oct 5, 1999·50 cites·36 claims
- 2977US7781567B2Method for enzymatic production of GLP-2(1-33) and GLP-2(1-34) peptidesNPS PHARMA INC·Filed 2004·Granted Aug 24, 2010·4 cites·38 claims
- 3077US6796967B2Injection needle assemblyNPS PHARMA INC·Filed 2001·Granted Sep 28, 2004·91 cites·30 claims
- 3177US6710088B2Inorganic ion receptor-active compoundsNPS PHARMA INC·Filed 2002·Granted Mar 23, 2004·8 cites·26 claims
- 3274US6617358B1Anticonvulsant and central nervous system-depressing bis(fluorophenyl)alkylamides and their usesNPS PHARMA INC·Filed 2000·Granted Sep 9, 2003·7 cites·19 claims
- 3373US9592273B2Treatment of short bowel syndrome patients with colon-in-continuityNPS PHARMA INC·Filed 2016·Granted Mar 14, 2017·0 cites·8 claims
- 3473US9572867B2Treatment of short bowel syndrome patients with colon-in-continuityNPS PHARMA INC·Filed 2016·Granted Feb 21, 2017·0 cites·8 claims
- 3573US9555079B1Treatment of short bowel syndrome patients with colon-in-continuityNPS PHARMA INC·Filed 2016·Granted Jan 31, 2017·0 cites·8 claims
- 3673US9545435B1Treatment of short bowel syndrome patients with colon-in-continuityNPS PHARMA INC·Filed 2016·Granted Jan 17, 2017·0 cites·17 claims
- 3773US9539310B1Treatment of short bowel syndrome patients with colon-in-continuityNPS PHARMA INC·Filed 2016·Granted Jan 10, 2017·0 cites·12 claims
- 3873US6589994B1Treating a variety of pathological conditions, including spasticity and convulsions, by effecting a modulation of CNS activity with isovaleramide, isovaleric acid, or a related compoundNPS PHARMA INC·Filed 1999·Granted Jul 8, 2003·27 cites·1 claims
- 3973US6432656B1Calcilytic compoundsNPS PHARMA INC·Filed 1999·Granted Aug 13, 2002·41 cites·9 claims
- 4071US7262280B1G-protein fusion receptors and constructs encoding sameNPS PHARMA INC·Filed 2000·Granted Aug 28, 2007·4 cites·28 claims
- 4171US6521667B1Calcilytic compoundsNPS PHARMA INC·Filed 1998·Granted Feb 18, 2003·28 cites·12 claims
- 4271US5981195AChimeric receptors and methods for identifying compounds active at metabotropic glutamate receptorsNPS PHARMA INC·Filed 1996·Granted Nov 9, 1999·17 cites·48 claims
- 4369US6342532B1Inorganic ion receptor active compoundsNPS PHARMA INC·Filed 1999·Granted Jan 29, 2002·22 cites·21 claims
- 4466US5506268AUse of isovaleramide as a mild anxiolytic and sedative agentNPS PHARMA INC·Filed 1993·Granted Apr 9, 1996·15 cites·15 claims
- 4565US5688764AInsecticidal peptides from spider venomNPS PHARMA INC·Filed 1995·Granted Nov 18, 1997·15 cites·38 claims
- 4664US7781401B2Glucagon-like peptide-2 analogsNPS PHARMA INC·Filed 2002·Granted Aug 24, 2010·0 cites·16 claims
- 4763US2014256632A1Methods useful in the treatment of bone resorption diseasesNPS PHARMA INC·Filed 2014·Application pending·0 cites
- 4862US7829307B2Production of glucagon-like peptide 2NPS PHARMA INC·Filed 2004·Granted Nov 9, 2010·2 cites·4 claims
- 4961US8846625B2Glucagon-like peptide-2 analogsNPS PHARMA INC·Filed 2013·Granted Sep 30, 2014·0 cites·13 claims
- 5060US8980567B2Ex vivo method for determining potential GLP-2 receptor modulatorsNPS PHARMA INC·Filed 2013·Granted Mar 17, 2015·0 cites·16 claims
Showing the top 50 of 103 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when NPS PHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →